Home/Filings/4/0002050035-26-000002
4//SEC Filing

Issa Mohamed Khairie 4

Accession 0002050035-26-000002

CIK 0000879169other

Filed

Jan 7, 7:00 PM ET

Accepted

Jan 8, 4:03 PM ET

Size

6.6 KB

Accession

0002050035-26-000002

Insider Transaction Report

Form 4
Period: 2026-01-06
Issa Mohamed Khairie
EVP, Head of US Oncology
Transactions
  • Tax Payment

    Common Stock

    2026-01-06$106.66/sh8,264$881,43876,988 total
  • Sale

    Common Stock

    2026-01-07$109.07/sh10,856$1,184,06466,132 total
Footnotes (2)
  • [F1]Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock.
  • [F2]This includes an aggregate of 66,132 shares of common stock issuable pursuant to previously reported RSUs that have not vested.

Issuer

INCYTE CORP

CIK 0000879169

Entity typeother

Related Parties

1
  • filerCIK 0002050035

Filing Metadata

Form type
4
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 4:03 PM ET
Size
6.6 KB